Company Quick10K Filing
Bone Biologics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-07-31 Quarter: 2014-07-31
10-Q 2014-04-30 Quarter: 2014-04-30
10-Q 2014-01-31 Quarter: 2014-01-31
10-K 2013-10-31 Annual: 2013-10-31
8-K 2019-09-19 Enter Agreement, Exhibits
8-K 2019-06-28 Enter Agreement, Officers, Exhibits
8-K 2019-04-09 Enter Agreement, Exhibits
8-K 2019-03-25 Other Events, Exhibits
8-K 2018-09-12 Shareholder Vote
8-K 2018-08-01
8-K 2018-07-16 Enter Agreement, Sale of Shares, Control, Officers, Other Events, Exhibits
8-K 2018-06-11 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-03-26 Enter Agreement, Sale of Shares, Other Events, Exhibits

Bone Biologics Financials

-

BBLG Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash000000000000152,6612,1693,1672,1261,1154,2212,1946886201,6127831,6226903713052,294955726176
Accounts Receivable
Inventory
PP&E121212121011111111000000
Assets000000000004203,8213,2164,4133,3022,0804,6222,6351,0729731,9681,1401,9407964703782,3501,041814266
Accounts Payable20032561872832733362277311422521726226065125518178
Long-Term Debt
Liabilities2930323435373839404244454,7727,5207,8005,3115,5007,7617,6347,9508,1239,60710,23811,39012,8459,1919,0059,8349,5259,63910,78611,122
Stockholders' Equity-29-30-32-34-35-36-38-39-40-42-44-45-4,352-3,699-4,584-898-2,199-5,681-3,012-5,316-7,050-8,634-8,270-10,250-10,904-8,396-8,534-9,456-7,174-8,598-9,972-10,855
Income Statement ($'000)2011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue00000000000000000000000000000
Cost of Revenue00000000000000000000
Gross Profit00000000000000000000
R&D2561841881753033,0014,6782,3192,4732,1321,191-3,094248461402356-1,049549564418
SG&A
Tax00000000102070201-10200020002
Net Income-1-2-1-2-1-1-1-2-2-1-2,613-4,419-1,642-891-3,363-7,981-6,978-4,800-4,372-4,879-3,0742,163-2,527-2,315-1,455-191-242-1,471-1,407-926
Cash Flow ($'000)2011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating000-0-0-5-1-2-1-1-842-2,751-492-1,003-1,040-1,011-2,527-2,027-1,506-1,268-1,008-829-561-932-819-667-1,280-1,339-929-1,550
Cash Investing00000000-12-10000000
Cash Financing00000511118195,386005,633001,2002,00001,40005006003,27007001,000